INTRODUCTION
============

Rationale and Background Information
------------------------------------

Cranioplasty is performed to replace missing or damaged cranium following craniectomies and craniotomies. Studies have demonstrated clear benefits of this procedure, including appearance restoration, cognitive function improvement, increased cerebral blood flow, and increased patient satisfaction and quality of life.^[@R1]--[@R3]^ Cranioplasty has an extensive history of use and can be performed with autologous bone or a variety of alloplastic implants.^[@R4],[@R5]^

While there have been single institution^[@R6]--[@R8]^ and nationwide^[@R9]^ studies demonstrating that cranioplasty conveys significant risk, there have been no studies to date examining morbidity and mortality of the cranioplasty procedure using a nationally validated, peer-controlled database.^[@R10]^ Such a study would provide patients and providers with an understanding of risks for postoperative complication. This would allow for more informed decision-making before surgery and help to guide the timing of cranioplasty procedures.

The American College of Surgeons National Surgical Quality Improvement Program is a national surgical database that contains demographic, comorbidity, operative, and complication data from hundreds of participating hospitals across the United States.^[@R11]^ The magnitude and reliability of this database made it an ideal tool with which to examine the morbidity and mortality of cranioplasty.

Study Goals and Objectives
--------------------------

This study aims to utilize the NSQIP database to assess (1) the risk factors associated with all-cause complication following cranioplasty, (2) the effect of size of cranioplasty implant on complication rates, and (3) the effect of cranioplasty type on complication rates.

METHODS
=======

Study Design
------------

The NSQIP database for the years 2015--2016 was surveyed for patients who had undergone cranioplasty. Cases were identified based on current procedural terminology (CPT) codes. Cases were subgrouped according to whether the patients received an alloplastic (CPT 62140 and 62141), autologous (CPT 62146 and 62147), or other type of cranioplasty---including "replacement of bone flap or prosthetic plate of skull" and "cranioplasty for skull defect with reparative brain surgery" (CPT 62143 and 62145). In the autologous and alloplastic groups, cases were categorized based on whether the implant was \<5 cm (CPT 62140 and 62146) or \>5 cm (CPT 62141 and 62147).

Variables Studied
-----------------

Demographic, comorbidity, and operative characteristic data were collected including age, gender, race, diabetes, smoking status, dyspnea, ventilator dependency, COPD, ascites, congestive heart failure within the past 30 days, hypertension, acute renal failure, dialysis status, disseminated cancer, steroid use for chronic condition, \>10% loss in body weight in the last 6 months, systemic sepsis, bleeding disorders, pre-op transfusion of \>1 units of RBC, inpatient status, wound class, ASA class, total wRVU, and total operative time. BMI was calculated from height and weight data.

Surgical and medical complications were tabulated. Surgical complications included superficial infection, wound infection, organ space SSI, and wound disruption. Medical complications included pneumonia, reintubation, pulmonary embolism, failure to wean from respirator, progressive renal insufficiency, acute renal failure, UTI occurrence, CVA/stroke with neurological deficit, cardiac arrest requiring CPR, myocardial infarction, bleeding transfusions, DVT/thrombophlebitis, sepsis, and septic shock. Overall complications rates included all medical complications and surgical complications, as well as death within 30 days of surgery, any readmission, and unplanned reoperation.

Missing Data
------------

Patients with missing data were excluded from the analyses that corresponded with their missing data. Thirty-two patients lacked weight and/or height data, and therefore their BMI could not be calculated. One patient's age was coded as 90+, and thus this patient was excluded from the age data. This patient was also excluded from the multivariate analysis. Sample sizes are listed next to the age and BMI data, the 2 variables in which there was missing data.

Statistical Analysis
--------------------

Statistical analyses were conducted using IBM SPSS Statistics 25. Demographic analysis was ascertained utilizing descriptive statistics including the Fisher exact test and χ^2^ test for categorical data and ANOVA for numerical data. The univariate analysis was also performed with the χ^2^ test, the Fisher exact test, and ANOVA. The multivariate analysis was performed using binary logistic regression including the data in the univariate analysis found to be significant or approaching significance. A *P*-value \< 0.05 was deemed significant, and *P*-values \< 0.10 were deemed as approaching significance.

RESULTS
=======

From the study population (2015--2016 NSQIP data), 697 patients were included. Of the 697 patients, 1 patient received both an alloplastic and autologous cranioplasty, and 1 patient received both an alloplastic and "other" cranioplasty. These 2 cases were included in both of the corresponding groups. In total, 543 cranioplasties were alloplastic, 57 were autologous, and 99 were classified as "other."

Demographic, comorbidity, and operative characteristic data between the cranioplasty types is described in Table [1](#T1){ref-type="table"}. Demographic, comorbidity, and operative characteristics were compared between the autologous, alloplastic, and "other" subgroups (Table [1](#T1){ref-type="table"}). Age (*P* = 0.028), race (*P* \<0.001), disseminated cancer (*P* = 0.023), systemic sepsis (*P* = 0.002), ASA class (*P* = 0.002), total wRVU (*P* \<0.001), and total operative time (*P* = 0.025) were found to significantly differ between the types of cranioplasty procedures.

###### 

Demographic Data, Comorbidities, and Operative Data Were Compared in Patients with Alloplastic Versus Autologous Versus Other Cranioplasty Types

                                         Cranioplasty Type         *P*                                                                        
  -------------------------------------- ------------------------- ------- ------------------------ ------- ------------------------- ------- --------------
  Demographics                                                                                                                                
   Age (n = 698)                         55.34 ± 15.86 (n = 542)           49.84 ± 15.68 (n = 57)           56.36 ±1 4.195 (n = 99)           **0.028\***
   BMI (n = 667)                         28.93 ± 7.20 (n = 530)            31.21 ± 7.85 (n = 52)            29.445 ± 6.54 (n = 85)            0.087
   Gender                                                                                                                                     0.15
    Male                                 231                       42.50   20                       35.10   50                        50.50   
    Female                               312                       57.50   37                       64.90   49                        49.50   
   Race                                                                                                                                       **\<0.001**‡
    American Indian or Alaska            3                         0.60    1                        1.8     0                         0.0     
   Native                                                                                                                                     
    Asian                                19                        3.50    2                        3.5     2                         2.0     
    Black or African American            52                        9.60    7                        12.3    4                         4.0     
    Native Hawaiian or Pacific           1                         0.20    0                        0.0     0                         0.0     
   Islander                                                                                                                                   
    Unknown/not reported                 69                        12.70   15                       26.3    43                        43.4    
    White                                399                       73.50   32                       56.1    50                        50.5    
  Comorbidities                                                                                                                               
   Diabetes                                                                                                                                   0.32
    Insulin                              24                        4.4     1                        1.8     5                         5.1     
    Non-insulin                          44                        8.1     5                        8.8     14                        14.1    
   Current smoker                        112                       20.6    14                       24.6    18                        18.2    0.62
   Dyspnea                                                                                                                                    0.81
   At rest                               3                         0.6     0                        0.0     1                         1.0     
   Moderate exertion                     19                        3.5     2                        3.5     2                         2.0     
   Ventilator dependent                  6                         1.1     0                        0.0     2                         2.0     0.53
   COPD                                  21                        3.9     0                        0.0     4                         4.0     0.43
   Ascites                               0                         0.0     0                        0.0     0                         0.0     
   CHF \<30 d                            2                         0.4     0                        0.0     1                         1.0     0.53
   Hypertension                          199                       36.6    20                       35.1    41                        41.4    0.62
   Acute renal failure                   0                         0.0     0                        0.0     1                         1.0     0.22
   Currently on dialysis                 2                         0.4     0                        0.0     0                         0.0     1.00
   Disseminated cancer                   89                        16.4    3                        5.3     21                        21.2    **0.023\***
   Open wound/wound infection            17                        3.1     0                        0.0     4                         4.0     0.34
   Steroid use for chronic condition     51                        9.4     5                        8.8     12                        12.1    0.67
   \>10% loss body weight in last 6 mo   9                         1.2     0                        0.0     4                         4.0     0.18
   Systemic sepsis (any)                                                                                                                      **0.002†**
   Sepsis                                0                         0.00    1                        1.80    2                         2.0     
   Septic shock                          0                         0.00    0                        0.00    1                         1.0     
   SIRS                                  27                        5.00    0                        0.00    2                         2.0     
   Bleeding disorders                    16                        2.90    3                        5.30    3                         3.0     0.62
   Pre-op transfusion \>1 units RBC      2                         0.40    0                        0.00    1                         1.0     0.53
   Inpatient status                      527                       97.10   55                       96.50   98                        99.0    0.58
  Operative Characteristics                                                                                                                   
    Wound class                                                                                                                               0.24
   1. Clean                              488                       89.90   47                       82.50   90                        90.9    
   2. Clean-contaminated                 32                        5.90    5                        8.80    6                         6.1     
   3. Contaminated                       12                        2.20    3                        5.30    0                         0.0     
   4. Infected                           11                        2.00    2                        3.50    3                         3.0     
   ASA class                                                                                                                                  **0.002†**
   Class 1                               16                        2.90    3                        5.30    0                         0       
   Class 2                               151                       27.30   22                       38.60   20                        20.20   
   Class 3                               308                       56.70   27                       47.40   53                        53.50   
   Class 4                               62                        11.40   4                        7.00    25                        25.30   
   Class 5                               1                         0.20    0                        0       1                         1.00    
   None assigned                         5                         0.90    1                        1.80    0                         0       
   Total wRVU                            37.8409±12.17796                  33.5663±8.93116                  32.5189±8.19076                   **\<0.001‡**
    Total operative time                 262.8±163.703                     290±183.897                      222.37±141.969                    **0.025\***

Significant findings are in bold font.

\* *P* value \< 0.05.

† *P* value \< 0.01.

‡ *P* value \< 0.001.

CHF, congestive heart failure.

Complication frequencies are described in Table [2](#T2){ref-type="table"}. Twenty-one (3.0%) patients died within 30 days of surgery. Many patients had \>1 complication, and a total of 191 patients (27.4%) from the sample experienced 1 or more complications.

###### 

Complication Numbers and Percentages Are Listed for the Entire Sample Size of Patients Who Underwent Cranioplasty

  Outcome                                                   Count   Percentage
  --------------------------------------------------------- ------- ------------
  Surgical complications                                            
   Occurrences superficial infection (SUPINFEC)             7       1.0
   Occurrences deep incisional SSI (WNDINF)                 4       0.6
   Occurrences organ space SSI (ORGSPSSI)                   11      1.6
   Occurrences wound disruption (DEHIS)                     6       0.9
  Medical complications                                             
   Occurrences pneumonia (OUPNEUMO)                         17      2.4
   Occurrences reintubation (REINTUB)                       15      2.2
   Occurrence pulmonary embolism (PULEMBOL)                 4       0.6
   Occurrence failure to wean from respirator (FAILWEAN)    28      4.0
   Occurrences progressive renal insufficiency (RENAINSF)   4       0.6
   Occurrences acute renal failure (OPRENAFL)               2       0.3
   Occurrences UTI (URNINFEC)                               14      2.0
   CVA/stroke with neurological deficit (CNSCVA)            15      2.2
   Occurrences cardiac arrest requiring CPR (CDARREST)      3       0.4
   Occurrences myocardial infarction (CDMI)                 0       0.0
   Occurrences bleeding transfusions (OTHBLEED)             58      8.3
   Occurrences DVT/thrombophlebitis (OTHDVT)                17      2.4
   Occurrences sepsis (OTHSYSEP)                            17      2.4
   Occurrences septic shock (OTHSESHOCK)                    1       0.1
  Death, readmission, and reoperation                               
   Death                                                    21      3.0
   Readmission                                              70      10.0
   Return to OR                                             56      8.0
  Total                                                             
   No. patients with 1+ complications                       191     27.4

In the univariate analysis (Table [3](#T3){ref-type="table"}), age (*P* \< 0.001), race (*P* = 0.030), diabetes (*P* = 0.046), ventilator dependency (*P* = 0.039), congestive heart failure (*P* = 0.020), hypertension (*P* = 0.001), open wound/wound infection (*P* = 0.013), systemic sepsis (*P* = 0.005), and bleeding disorders (*P* = 0.007) were found to be significantly correlated with any complication outcome. Dialysis status (*P* = 0.075) and \>10% loss of body weight (*P* = 0.053) approached significance, and were thus included in the multivariate analysis.

###### 

In the Univariate Analysis, Demographics, Comorbidities, and Operative Data Were Compared in Patients Who Developed Complications within 30 Days Versus Patients Who Did Not

                                                         Complications                           No Complications   P
  ------------------------------------------------------ --------------------------------------- ------------------ ----------
  Demographics                                                                                                      
   Age (n = 696)                                         58.47 ± 15.84                           53.77 ± 15.42      \<0.001‡
   BMI (n = 665)                                         29.66 ± 7.70                            29.01 ± 6.97       0.30
                                                         Complication occurrencesTotal n = 697   Percentage         
   Gender                                                                                                           0.67
   Male (n = 300)                                        85                                      28.30              
   Female (n = 397)                                      106                                     26.70              
   Race                                                                                                             0.030\*
    American Indian or Alaska Native (n = 4)             0                                       0                  
    Asian (n =23)                                        6                                       26.10              
    Black or African American (n = 63)                   26                                      41.30              
    Native Hawaiian or Pacific Islander (n = 1)          1                                       100                
    White (n = 480)                                      131                                     27.30              
    Unknown/Not Reported (n = 126)                       27                                      21.40              
  Comorbidities                                                                                                     
   Diabetes                                                                                                         0.046\*
    Diabetic with insulin (n = 30)                       14                                      46.70              
    Diabetic with non-insulin agents (n = 63)            19                                      30.20              
    Not diabetic (n = 604)                               158                                     26.20              
   Current smoker                                                                                                   1.00
    Smoker (n = 144)                                     39                                      27.10              
    Nonsmoker (n = 553)                                  152                                     27.50              
   Dyspnea                                                                                                          0.18
    Dyspnea at rest (n = 4)                              1                                       25                 
    Dyspnea with moderate exertion (n = 23)              10                                      43.50              
    No Dyspnea (n = 670)                                 180                                     26.90              
   Ventilator dependent                                                                                             0.039\*
    Dependent (n = 8)                                    5                                       62.50              
    Not dependent (n = 689)                              186                                     27.00              
   COPD                                                                                                             0.17
    History of severe COPD (n = 25)                      10                                      40                 
    No COPD history (n = 672)                            181                                     26.90              
   CHF \<30 d                                                                                                       0.020\*
    Congestive heart failure (n = 3)                     3                                       100                
    No heart failure (n = 694)                           188                                     27.10              
   Hypertension                                                                                                     0.001†
    Hypertension requiring medication (n = 260)          91                                      35.00              
    No hypertension (n = 437)                            100                                     22.90              
   Acute renal failure                                                                                              0.27
    Yes (n = 1)                                          1                                       100                
    No (n = 696)                                         190                                     27.30              
   Currently on dialysis                                                                                            0.075
    Yes (n = 2)                                          2                                       100                
    No (n = 695)                                         189                                     27.20              
   Disseminated cancer                                                                                              0.73
    Yes (n = 113)                                        29                                      25.70              
    No (n = 584)                                         162                                     27.70              
   Open wound/wound infection                                                                                       0.013\*
    Yes (n = 21)                                         11                                      52.40              
    No (n = 676)                                         180                                     26.60              
   Steroid use for chronic condition                                                                                0.67
    Steroid use for chronic condition (n = 67)           20                                      29.90              
    No steroid use (n = 630)                             171                                     27.10              
   \>10% loss body weight in last 6 months                                                                          0.053
    Yes (n = 13)                                         7                                       53.80              
    No (n = 684)                                         184                                     26.90              
   Systemic sepsis (any)                                                                                            0.005†
    Sepsis (n = 3)                                       2                                       66.70              
    Septic Shock (n = 1)                                 1                                       100                
    SIRS (n = 29)                                        14                                      48.30              
    None (n = 664)                                       174                                     26.20              
   Inpatient status                                                                                                 0.31
    Inpatient (n = 678)                                  188                                     27.70              
    Outpatient (n = 19)                                  3                                       15.80              
   Bleeding disorders                                                                                               0.007†
    Yes (n = 22)                                         12                                      54.50              
    No (n = 675)                                         179                                     26.50              
   Transfusion of ≥1 units RBC 72 hours before surgery                                                              1.00
    Yes (n = 3)                                          1                                       33.30              
    No (n = 694)                                         190                                     27.40              

Significant findings are in bold font.

CHF, congestive heart failure.

In the multivariate analysis (Table [4](#T4){ref-type="table"}), age (*P* = 0.029), systemic sepsis (*P* = 0.015), open wound/wound infection (*P* = 0.046), and bleeding disorders (*P* = 0.045) were found to be significantly correlated with any complication outcome.

###### 

In the Multivariate Analysis, Factors Found in the Univariate Analysis to Be Significant (*P* \< 0.05) or Approaching Significance (*P* \< 0.10) Were Evaluated for Significance in a Binary Logistic Regression

                                                       Odds Ratio   95% Confidence Interval   Sig.     
  ---------------------------------------------------- ------------ ------------------------- -------- -------------
  Age of patient with patients over 89 coded as 90+    1.014        1.001                     1.027    **0.029\***
  White                                                                                                0.426
  American Indian or Alaska Native                     0.000        0.000                              0.999
  Asian                                                1.201        0.456                     3.163    0.710
  Black or African American                            1.662        0.921                     3.002    0.092
  Native Hawaiian or Pacific Islander                  †            0.000                              1.000
  Unknown/not reported                                 0.756        0.464                     1.231    0.260
  Diabetes mellitus with non-insulin oral agents                                                       0.234
  Diabetes mellitus with insulin                       2.105        0.818                     5.417    0.123
  No diabetes                                          1.087        0.583                     2.028    0.792
  Ventilator dependent                                 2.671        0.551                     12.938   0.222
  Congestive heart failure in 30 days before surgery   †            0.000                              0.999
  Hypertension requiring medication                    1.303        0.870                     1.952    0.198
  Currently on dialysis (pre-op)                       †            0.000                              0.999
  \>10% loss body weight in last 6 months              2.804        0.889                     8.844    0.078
  Open wound/wound infection                           2.610        1.019                     6.682    **0.046\***
  Systemic Sepsis                                      2.684        1.216                     5.926    **0.015\***
  Bleeding disorders                                   2.589        1.021                     6.561    **0.045\***

Significant findings are in bold font.

\* *P* value \<0.05.

† Too high to be reported.

Cranioplasty complication rates did not vary significantly based on type (Table [5](#T5){ref-type="table"}). Rates of overall complications (*P* \< 0.001) and medical complications (*P* \< 0.001) were significantly different between cranioplasties \<5 cm and \>5 cm (Table [6](#T6){ref-type="table"}) (see table, Supplemental Digital Content 1, which lists the numerical value of specific complications by cranioplasty type, <http://links.lww.com/PRSGO/B266>) (see table, Supplemental Digital Content 2, which lists the specific complications by cranioplasty size, <http://links.lww.com/PRSGO/B267>).

###### 

The Outcome of Overall, Medical, or Surgical Complications Was Compared between Alloplastic, Autologous, and "Other" Cranioplasty Groups

                                 Cranioplasty Type                   
  ------------------- ---------- ------------------- ------- ------- ------
  Complication Type   Overall    28.00               24.60   27.30   0.86
                      Surgical   3.50                3.50    2.00    0.75
                      Medical    17.50               22.80   15.20   0.48

\*\*Overall complication rates include medical complications, surgical complications, death, reoperation and readmission.

###### 

The Outcome of Overall Complications, Medical Complications, Surgical Complications, and Death Was Compared between Procedures with Cranioplasty \>5 cm and Those with Cranioplasty \<5 cm

                           Defect Size                        
  ------------------------ ------------- ------- ---- ------- --------------
  Overall complications†   85            22.10   79   37.30   **\<0.001**‡
  Medical complications    44            11.40   63   29.70   **\<0.001**‡
  Surgical complications   13            3.40    7    3.30    0.96
  Death                    8             2.10    7    3.30    0.36

Significant findings are in bold font.

\*Two patients who had a \>5 cm and \<5 cm implant were excluded.

†Overall complications include death, reoperation, and readmission as well as surgical and medical complications.

‡*P* value \< 0.001.

DISCUSSION
==========

In this analysis, 697 patients were identified in the NSQIP database as having undergone cranioplasty. The mortality within 30 days of the procedure was 3.0% and the presence of any complication 30 days after surgery was 27.4%. Comparable mortality and complication rates have been found in the literature.^[@R6]--[@R8],[@R12],[@R13]^

There are discrepancies in past reports on the complication profiles of different cranioplasty types. Past studies have demonstrated lower rates of surgical complications in synthetic implants as opposed to autografts,^[@R14]^ higher complication rates in non-autogenous versus autogenous grafts,^[@R15]^ or no difference between autografts and allografts.^[@R16],[@R17]^ Our analysis found no significant differences in medical, surgical, and overall complications between the cranioplasty types.

While implant material did not appear to influence morbidity, implant size did. Larger implants were associated with higher overall complications (*P* \< 0.001) and medical complications (*P* \< 0.001). Other studies have also found a relationship between implant size and complications.^[@R9],[@R18]^ Patients needing larger implants often have a higher degree of trauma and infection before cranioplasty surgery, which may contribute to their poorer postoperative outcomes.

Of the variety of variables evaluated in the multivariate analysis, age, bleeding disorders, open wound/wound infection, and systemic sepsis were found to significantly increase the risk of complication. Age has been found to increase postsurgical morbidity in cranioplasty and neurosurgical procedures as a whole.^[@R13],[@R19],[@R20]^ While some studies recommend that age alone should not be used rule out surgery,^[@R20]^ age should be included in the discussion with the prospective cranioplasty patient since for every 1 year increase in age the morbidity of cranioplasty increases by 1.4% (Table [4](#T4){ref-type="table"}).

Open wounds (with or without infection) before surgery were also associated with an increased risk of complication. The odds of developing complication in patients with open wounds (relative to no wounds) were 2.61:1. Craniectomies and craniotomies, which are performed before cranioplasty, carry a sizeable risk of postoperative dehiscence.^[@R21],[@R22]^ Wound dehiscence from these procedures impacts future wound healing, leads to hospital readmission, and increases risk of future infection.^[@R21]--[@R24]^ It follows that individuals with an open wound before surgery would have an increased risk of complications post-cranioplasty. While some would recommend delaying cranioplasty in the setting of open wounds and infection,^[@R7]^ this must be weighed with the risk of the neurological complications that can occur when cranioplasty is postponed.^[@R25]^

Bleeding disorders were also significantly associated with complications. Patients with bleeding disorders require complex management when undergoing surgical procedures, and the degree of risk surgery confers depends heavily on the severity of their disease and their medical regimen.^[@R26]^ This study found that the odds of patients with bleeding disorders developing complications when compared with controls were 2.59:1. As such, caution and appropriate intraoperative management are recommended for patients with bleeding disorders before cranioplasty.

Systemic sepsis---including sepsis, septic shock, and SIRS---was also associated with postoperative morbidity. The odds of developing any complication in septic patients versus non-septic patients were 2.68:1. Even outside of the surgical setting, septic patients are at drastically increased risk of death and acute organ failure.^[@R27],[@R28]^ Subjecting such high-risk patients to surgery puts them at additional risk for death, lung, liver, and renal failure, as well as a host of other complications.^[@R29]^ Due to the high rates of complication following cranioplasty in septic patients, the patient and the surgical team should evaluate whether the procedure is worth the risks to the patient's overall health.

Limitations
-----------

This study is limited by the nature and scope of the NSQIP database. While this database contains comprehensive morbidity data 30 days postoperatively, outcomes beyond that point are lost. Past studies have followed patients from a couple of months to several years after cranioplasty to monitor for any complications.^[@R3],[@R14],[@R17],[@R30]^ Many complications, such as bone resorption, infection, and exposure of implant material may take a longer time to manifest, and thus would be missed by this study.

Another limitation of this study is that a wide variety of implant materials are considered alloplastic implants---including titanium, polymethyl-methacrylate, polyether-ketone-ketone, and hydroxyapatite. However, there was no way to differentiate these further based on the NSQIP data. Different alloplastic materials may have different complication profiles.^[@R12],[@R31],[@R32]^ Thus, the heterogeneity of the alloplastic group should be taken into consideration in light of the similar complication profiles between the autologous, alloplastic, and "other" cranioplasty group.

Lastly, the univariate analysis results informed the multivariate model selection. More robust findings may have been made evident with a more sophisticated statistical model.

CONCLUSIONS
===========

In conclusion, cranioplasty is a morbid procedure, with a complication rate of 27.4% and a mortality rate of 3.0% in this national sample. Factors such as age, sepsis, open wound/wound infection, bleeding disorders, and size increase risk. Identification and modification of risk factors may guide operative timing and influence informed consent.
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